Ortin Laboratories
Ortin Laboratories Performance
Day Range
- Low 19.1
- High 20
52 Week Range
- Low 16.2
- High 30.35
- Open Price20
- Previous Close19.3
- Volume564
Start SIP in Ortin Laboratories
Start SIPOrtin Laboratories Investment Rating
-
Master Rating:
-
Ortin Laboratories has an operating revenue of Rs. 4.97 Cr. on a trailing 12-month basis. An annual revenue de-growth of -28% needs improvement, Pre-tax margin of -1% needs improvement, ROE of -0% is poor and needs improvement. The company has a reasonable debt to equity of 27%, which signals a healthy balance sheet. From an O'Neil Methodology perspective, the stock has an EPS Rank of 57 which is a POOR score indicating inconsistency in earnings, a RS Rating of 11 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at D- which indicates heavy supply, Group Rank of 112 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of D is close to being the worst. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Please note that this is a thinly traded stock.
EPS Strength
Price Strength
Buyer Demand
Group Rank
Indicator | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
---|---|---|---|---|---|---|
Oper Rev Qtr Cr | 2 | 1 | 1 | 1 | 3 | 2 |
Operating Expenses Qtr Cr | 1 | 2 | 1 | 1 | 2 | 3 |
Operating Profit Qtr Cr | 0 | 0 | 1 | 0 | 0 | 0 |
Depreciation Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 |
Interest Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 |
Tax Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 |
Net Profit Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 |
Ortin Laboratories Technicals
EMA & SMA

- Bullish Moving Average
- ___
- 0
- Bearish Moving Average
- ___
- 16
- 20 Day
- ₹19.69
- 50 Day
- ₹19.99
- 100 Day
- ₹20.41
- 200 Day
- ₹21.23
- 20 Day
- ₹19.73
- 50 Day
- ₹19.85
- 100 Day
- ₹20.54
- 200 Day
- ₹21.32
Ortin Laboratories Resistance and Support
Resistance | |
---|---|
First Resistance | ₹19.59 |
Second Resistance | ₹19.87 |
Third Resistance | ₹20.09 |
RSI | 40.71 |
MFI | 28.73 |
MACD Single Line | -0.09 |
MACD | -0.1 |
Support | |
---|---|
First Resistance | ₹19.09 |
Second Resistance | ₹18.87 |
Third Resistance | ₹18.59 |
Ortin Laboratories Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 6,391 | 639,100 | 100 |
Week | 9,970 | 997,000 | 100 |
1 Month | 11,625 | 1,162,510 | 100 |
6 Month | 63,774 | 3,965,472 | 62.18 |
Ortin Laboratories Result Highlights
Ortin Laboratories Synopsis
NSE-Medical-Diversified
Ortin Laborator. belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 6.02 Cr. and Equity Capital is Rs. 8.13 Cr. for the Year ended 31/03/2023. Ortin Laboratories Ltd. is a Public Limited Listed company incorporated on 27/10/1986 and has its registered office in the State of Andhra Pradesh, India. Company’s Corporate Identification Number(CIN) is L24110TG1986PLC006885 and registration number is 006885.Market Cap | 16 |
Sales | 5 |
Shares in Float | 0.76 |
No of funds | |
Yield |
Book Value | 1.44 |
U/D Vol ratio | 0.6 |
LTDebt / Equity | 27 |
Alpha | -0.05 |
Beta | 0.22 |
Ortin Laboratories
Owner Name | Jun-23 | Mar-23 | Dec-22 | Sep-22 |
---|---|---|---|---|
Promoters | 7.36% | 21.51% | 15.68% | 15.68% |
Foreign Portfolio Investors | ||||
Individual Investors | 86.93% | 73.83% | 79.59% | 77.73% |
Others | 5.71% | 4.66% | 4.73% | 6.59% |
Ortin Laboratories Management
Name | Designation |
---|---|
Mr. J R K Panduranga Rao | Chairman & Managing Director |
Mr. S Murali Krishna Murthy | Managing Director |
Mr. S Srinivas Kumar | WholeTime Director & CFO |
Mr. G Venkata Ramana | Non Executive Director |
Mr. Bh Satyanarayana Raju | Non Executive Director |
Mr. S Balaji Venkateswarlu | Non Executive Director |
Mr. B Gopal Reddy | Independent Director |
Mr. Murali Krishna Rayaprolu | Independent Director |
Ms. Pottur Sujatha | Independent Director |
Ortin Laboratories Forecast
Price Estimates
Ortin Laboratories Corporate Action
Date | Purpose | Remarks |
---|---|---|
2023-08-14 | Quarterly Results | |
2023-05-30 | Audited Results | |
2023-02-14 | Quarterly Results | |
2022-11-14 | Quarterly Results | |
2022-08-13 | Quarterly Results |
- Company Name
- CMP
- Chg(%)
- Cipla
- 1184
- 1.8
- Dr Reddys Labs
- 5540
- 1.3
- LTIMindtree
- 5405
- 0.8
- Divis Lab.
- 3783
- 0.8
- Bharti Airtel
- 917
- 0.5
- Company Name
- CMP
- Chg(%)
Ortin Laboratories FAQs
What is Share Price of Ortin Laboratories ?
Ortin Laboratories share price is ₹19 As on 27 September, 2023 | 10:21
What is the Market Cap of Ortin Laboratories ?
The Market Cap of Ortin Laboratories is ₹15.5 Cr As on 27 September, 2023 | 10:21
What is the P/E ratio of Ortin Laboratories ?
The P/E ratio of Ortin Laboratories is 41.3 As on 27 September, 2023 | 10:21
What is the PB ratio of Ortin Laboratories ?
The PB ratio of Ortin Laboratories is 1.4 As on 27 September, 2023 | 10:21